Granulomatous reaction in hepatic inflammatory angiomyolipoma after chemoembolization and spontaneous rupture

Table 1 Summary of previously reported hepatic inflammatory angiomyolipoma and ruptured hepatic angiomyolipoma in the literature in English

	Age	Sex	Size/location	Signs of TSC	Clinical diagnosis	Melanocytic markers	Symptom/onset	Treatment	Follow up after surgery
Previous cases of hepatic inflammatory AML (n = 8)[5-8]	41.3 (mean)	Male: 1	6.5 cm (mean)	None (all cases)	IPT (by biopsy): 1	HMB 45 (+/-): 8/0	Pyrexia: 2	Elective resection (all cases)	All cases alive with no recurrence (follow up: 2-7 yr)
	21-63 (range)	Female: 7	3-10 cm (range)		Mass lesion (without biopsy): 7	Melan A (+/-): 5/2	Hepatic mass: 4
			Lt. lobe: 5				Abdominal discomfort: 2
			Rt. lobe: 3
Previous cases of ruptured hepatic AML (n = 7)[3,15-20]	45.1 (mean)	Male: 3	7.9 cm (mean)	Present: 1	Hepatic tumor: 4	HMB 45 (+): 2	Hemorrhagic shock: 2	Emergent resection: 3	Alive with no recurrence:1 (follow up: 2 yr)
	22-74 (range)	Female: 3	5-10.5 cm (range)	None: 6	Lipomatous tumor: 1	Melan A (+): 1	Upper abdominal pain: 3	Emergent laparotomy for hemostasis: 2	NA: 6
	NA: 1	NA: 1	Lt. lobe: 2		Hemangioma: 1	NA (HMB 45): 5	Unkown:2	Elective resection after emergent laparotomy for hemostasis: 1
			Rt. lobe: 5		Hepatic AML: 1	NA (Melan A): 6		Elective resection after TAE: 1
Present case	77	Female	2.5 cm Lt. lobe	None	HCC (without biopsy)	HMB 45: +	Hemorrhagic shock	Elective resection after TAE	Alive with no recurrence (3 yr)
						Melan A: +

TSC: Tuberous sclerosis complex; IPT: Inflammatory pseudotumor; HCC: Hepatocellular carcinoma; NA: Not available.